303 related articles for article (PubMed ID: 8658522)
1. Elevated sphingoid bases and complex sphingolipid depletion as contributing factors in fumonisin-induced cytotoxicity.
Yoo HS; Norred WP; Showker J; Riley RT
Toxicol Appl Pharmacol; 1996 Jun; 138(2):211-8. PubMed ID: 8658522
[TBL] [Abstract][Full Text] [Related]
2. Fumonisin inhibition of de novo sphingolipid biosynthesis and cytotoxicity are correlated in LLC-PK1 cells.
Yoo HS; Norred WP; Wang E; Merrill AH; Riley RT
Toxicol Appl Pharmacol; 1992 May; 114(1):9-15. PubMed ID: 1585377
[TBL] [Abstract][Full Text] [Related]
3. Disruption of sphingolipid metabolism and stimulation of DNA synthesis by fumonisin B1. A molecular mechanism for carcinogenesis associated with Fusarium moniliforme.
Schroeder JJ; Crane HM; Xia J; Liotta DC; Merrill AH
J Biol Chem; 1994 Feb; 269(5):3475-81. PubMed ID: 8106389
[TBL] [Abstract][Full Text] [Related]
4. Fumonisin B1 inhibits sphingosine (sphinganine) N-acyltransferase and de novo sphingolipid biosynthesis in cultured neurons in situ.
Merrill AH; van Echten G; Wang E; Sandhoff K
J Biol Chem; 1993 Dec; 268(36):27299-306. PubMed ID: 8262970
[TBL] [Abstract][Full Text] [Related]
5. Altered de novo sphingolipid biosynthesis is involved in the serum deprivation-induced cell death in LLC-PK1 cells.
Yu MU; Yoo JM; Lee YS; Lee YM; Hong JT; Oh KW; Song S; Yun YP; Yoo HS; Oh S
J Toxicol Environ Health A; 2004 Dec; 67(23-24):2085-94. PubMed ID: 15513905
[TBL] [Abstract][Full Text] [Related]
6. Sphingoid bases and their phosphates: transient activation and delayed repression of protein kinase C isoforms and their possible involvement in fumonisin B1 cytotoxicity.
Gopee NV; Sharma RP
Toxicology; 2003 May; 187(2-3):239-50. PubMed ID: 12699912
[TBL] [Abstract][Full Text] [Related]
7. Sphingolipid perturbations as mechanisms for fumonisin carcinogenesis.
Riley RT; Enongene E; Voss KA; Norred WP; Meredith FI; Sharma RP; Spitsbergen J; Williams DE; Carlson DB; Merrill AH
Environ Health Perspect; 2001 May; 109 Suppl 2(Suppl 2):301-8. PubMed ID: 11359699
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of fumonisin B1 on cell death in cultured cells: the significance of the elevated sphinganine.
Yu CH; Lee YM; Yun YP; Yoo HS
Arch Pharm Res; 2001 Apr; 24(2):136-43. PubMed ID: 11339633
[TBL] [Abstract][Full Text] [Related]
9. Evidence for disruption of sphingolipid metabolism as a contributing factor in the toxicity and carcinogenicity of fumonisins.
Riley RT; Wang E; Schroeder JJ; Smith ER; Plattner RD; Abbas H; Yoo HS; Merrill AH
Nat Toxins; 1996; 4(1):3-15. PubMed ID: 8680751
[TBL] [Abstract][Full Text] [Related]
10. Alteration of tissue and serum sphinganine to sphingosine ratio: an early biomarker of exposure to fumonisin-containing feeds in pigs.
Riley RT; An NH; Showker JL; Yoo HS; Norred WP; Chamberlain WJ; Wang E; Merrill AH; Motelin G; Beasley VR
Toxicol Appl Pharmacol; 1993 Jan; 118(1):105-12. PubMed ID: 8430417
[TBL] [Abstract][Full Text] [Related]
11. Dietary fumonisin B1 induces disruption of sphingolipid metabolism in Sprague-Dawley rats: a new mechanism of nephrotoxicity.
Riley RT; Hinton DM; Chamberlain WJ; Bacon CW; Wang E; Merrill AH; Voss KA
J Nutr; 1994 Apr; 124(4):594-603. PubMed ID: 8145083
[TBL] [Abstract][Full Text] [Related]
12. In vitro toxicology of fumonisins and the mechanistic implications.
Norred WP; Wang E; Yoo H; Riley RT; Merrill AH
Mycopathologia; 1992 Feb; 117(1-2):73-8. PubMed ID: 1513375
[TBL] [Abstract][Full Text] [Related]
13. Ceramide synthase inhibition by fumonisin B1 treatment activates sphingolipid-metabolizing systems in mouse liver.
He Q; Suzuki H; Sharma N; Sharma RP
Toxicol Sci; 2006 Dec; 94(2):388-97. PubMed ID: 16960033
[TBL] [Abstract][Full Text] [Related]
14. Fumonisin B(1) induces apoptosis in LLC-PK(1) renal epithelial cells via a sphinganine- and calmodulin-dependent pathway.
Kim MS; Lee DY; Wang T; Schroeder JJ
Toxicol Appl Pharmacol; 2001 Oct; 176(2):118-26. PubMed ID: 11601888
[TBL] [Abstract][Full Text] [Related]
15. Early fumonisin B1 toxicity in relation to disrupted sphingolipid metabolism in male BALB/c mice.
Tsunoda M; Sharma RP; Riley RT
J Biochem Mol Toxicol; 1998; 12(5):281-9. PubMed ID: 9664234
[TBL] [Abstract][Full Text] [Related]
16. Fumonisin B1 induces apoptosis in cultured human keratinocytes through sphinganine accumulation and ceramide depletion.
Tolleson WH; Couch LH; Melchior WB; Jenkins GR; Muskhelishvili M; Muskhelishvili L; McGarrity LJ; Domon O; Morris SM; Howard PC
Int J Oncol; 1999 May; 14(5):833-43. PubMed ID: 10200332
[TBL] [Abstract][Full Text] [Related]
17. Fumonisin-induced tumor necrosis factor-alpha expression in a porcine kidney cell line is independent of sphingoid base accumulation induced by ceramide synthase inhibition.
He Q; Riley RT; Sharma RP
Toxicol Appl Pharmacol; 2001 Jul; 174(1):69-77. PubMed ID: 11437650
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological antagonism of fumonisin B1 cytotoxicity in porcine renal epithelial cells (LLC-PK1): a model for reducing fumonisin-induced nephrotoxicity in vivo.
He Q; Riley RT; Sharma RP
Pharmacol Toxicol; 2002 May; 90(5):268-77. PubMed ID: 12076308
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of sphingolipid biosynthesis decreases phosphorylated ERK2 in LLC-PK1 cells.
Rentz SS; Showker JL; Meredith FI; Riley RT
Food Chem Toxicol; 2005 Jan; 43(1):123-31. PubMed ID: 15582204
[TBL] [Abstract][Full Text] [Related]
20. Persistence and reversibility of the elevation in free sphingoid bases induced by fumonisin inhibition of ceramide synthase.
Enongene EN; Sharma RP; Bhandari N; Miller JD; Meredith FI; Voss KA; Riley RT
Toxicol Sci; 2002 Jun; 67(2):173-81. PubMed ID: 12011476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
